Health & Medicine Tysabri safety and pml risk stratification april 2013

1. Natalizumab Safety Update &PML Risk StratificationApril 2013Gavin GiovannoniBarts and The London 2. Benefit / RiskBenefitRiskNatalizumab81% reduction inrelapse rate164%…

Health & Medicine Natalizumab safety and pml risk stratification march 2013

1. Natalizumab Safety Update & PML Risk Stratification Professor Gavin GiovannoniBarts and The LondonTY-PAN-0587(2) Date of preparation: March 2013 2. Benefit / Risk…